However, few longitudinal studies have evaluated how the immunemicroenvironment effects shedding.
2
The immunemicroenvironment plays an important role in the development of ES.
3
MPNST immunemicroenvironment does not correlate with patient outcome.
4
We explored relationships between radiomic features and molecular profiles of tumors, including the tumor immunemicroenvironment.
5
Within solid tumors, the status of the immunemicroenvironment provides valuable insight regarding potential responses to immune therapies.
6
In recent years, several noninvasive molecular imaging approaches have emerged as a platform to interrogate the tumor immunemicroenvironment.
7
We investigated the influence of tumor budding on prognosis and its association with the immunemicroenvironment in lung adenocarcinoma.
8
Conclusion: Our results suggest that conventional platinum-based chemotherapy negatively impacts the immunemicroenvironment at the time point of secondary progression.
9
Background and objectives: Limited literature exists examining the immunemicroenvironment in liposarcoma, particularly with regard to the impact of radiotherapy.
10
Conclusions: Tumor budding is an independent prognostic factor of stage I lung adenocarcinoma and correlates with the protumor immunemicroenvironment.
11
Utilizing single-cell approaches, we demonstrate B-ALL bone marrow immunemicroenvironment remodeling upon disease initiation and subsequent re-emergence during conventional chemotherapy.
12
Altogether, our data present greater insight into the impact of trametinib on the immunemicroenvironment and characteristics of trametinib-sensitive patient samples.
13
Our profiling of the B-ALL immunemicroenvironment identifies extrinsic regulators of B-ALL survival supporting new immune-based therapeutic approaches for high-risk B-ALL treatment.
14
Tumor growth inhibition by PD-1 and PD-L1 checkpoint blockade was potentiated in the UBM scaffold immunemicroenvironment.
15
Our findings and this resource may help to characterize the immunemicroenvironment, inform cancer immunotherapy and facilitate the development of precision immuno-oncology.
16
In conclusion, this study provides evidence for STAT3-mediated regulation of PD-L1 and modulation of immunemicroenvironment in BC.